General Practitioner responsibilities. 1. Reply to the request for shared care as soon as practicable, preferably within 2 weeks, by emailing back the shared care letter. If declining the request please indicate the reason for declining.
General Practitioner responsibilities. 1. Reply to the request for shared care as soon as practicable i.e. within 10 working days.
General Practitioner responsibilities. Prescribe Methylphenidate once notified by the specialist. Prescribe by brand for sustained release preparations. Ensure that the treatment is not continued if the patient fails to attend the specialist clinic for over a year. Check that patient is being monitored as specified in section on specialist responsibility. Report to and seek advice from the specialist on any aspect of patient care that is of concern to the GP and may affect treatment. Refer back to the specialist if the patient’s condition deteriorates. Monitor the patient for side effects and report all suspected adverse drug reactions (in children under 18 years of age), to the specialist and to the MHRA via xxx.xxxx.xxx.xx/xxxxxxxxxx Stop the treatment if advised by the specialist. Parent/carers role Ask the specialist or GP anything he or she does not understand about the treatment. Try to put into practice any behavioural or psychological programmes and report back to the specialist about their effectiveness. Report any adverse effects to the specialist or GP. Attend agreed review appointments. SUPPORTING INFORMATION Licensed indications Attention Deficit Hyperactivity Disorder (ADHD) is a heterogeneous behavioural syndrome characterised by the core symptoms of inattention, hyperactivity and impulsivity. ADHD should only be diagnosed by a specialist psychiatrist, paediatrician, or other healthcare professional with training and expertise in the diagnosis of ADHD. Diagnosis of ADHD should be made according to DSM-IV criteria or the guidelines in ICD-10 and should also be based on a complete history and evaluation of the patient, including a full clinical and psychosocial assessment, full developmental and psychiatric history, and assessment of mental state. Diagnosis cannot be made solely on the presence of one or more symptom. Methylphenidate is licensed for the treatment of ADHD in the UK. It should form part of a comprehensive treatment programme for ADHD that includes psychological, behavioural and educational advice and interventions. The indication for drug treatment is the presence of impairment resulting from ADHD. Therapeutic Use The aim of stimulant medication as part of a comprehensive treatment programme is to stabilise children with a behavioural syndrome characterised by symptoms which may include chronic history of short attention span, distractibility, emotional lability, impulsivity and moderate to severe hyperactivity. METHYLPHENIDATE
General Practitioner responsibilities. 1. Reply to the request for shared care as soon as practicable by emailing the request letter. 2. Continue the maintenance prescribing (normally for 12 months). 3. Monitor the alcohol consumption and general health normally on a monthly basis (see overleaf). 4. Promote patient compliance with disulfiram. 5. In the event of relapse to drinking or concerns over patient compliance, stop prescribing and refer patient back to the specialist. 6. Report to and seek advice from the specialist on any aspect of patient care that is of concern and may affect treatment. 7. Stop treatment on the advice of the specialist or immediately if an urgent need to stop treatment arises. Report adverse events to the MHRA on a Yellow Card (xxx.xxxx.xxx.xx/xxxxxxxxxx) and to the specialist, and appropriate Medicines Optimisation team. Patient/carer’s Role
General Practitioner responsibilities. 1. Following confirmation of dose stabilisation (after 2 weeks), consider the shared care request.
General Practitioner responsibilities. 1. Reply to the request for shared care as soon as practicable by faxing back signed form. If declining the request, please indicate the reason for declining.
General Practitioner responsibilities. 1. Reply to the request for shared care as soon as practicable by emailing back the request letter. 2. NB GPs may initiate treatment if at the advice of the community alcohol nurse/Community alcohol worker if the following criteria are met: 3. Patient has completed detoxification either at home or in the community setting. 4. Counselling is in place by either a community alcohol nurse or community alcohol worker. 5. Monitoring of drinking and general health will be done by the GP on a monthly basis in conjunction with community alcohol nurse or community alcohol worker. 6. (In this situation, the GP will be responsible for discontinuation of treatment.) 7. Continue the maintenance prescribing (normally for a maximum of 12 months). 8. Monitor the alcohol consumption and general health normally on a monthly basis (see overleaf) 9. Promote patient compliance with acamprosate. 10. In the event of relapse to drinking or concerns over patient compliance, refer patient back to the specialist. 11. Report to and seek advice from the specialist on any aspect of patient care that is of concern and may affect treatment. 12. Stop treatment on the advice of the specialist or immediately if an urgent need to stop treatment arises Report adverse events to the MHRA on a Yellow Card (xxx.xxxx.xxx.xx/xxxxxxxxxx), and to the specialist, and appropriate Medicines Optimisation team. Patient/carer’s Role
